New screener: ๐Ÿฆ Banks ranked by their 5 year credit default swap [external link]
GlaxoSmithKline
GSK
#197
Rank
$71.78 B
Marketcap
$35.06
Share price
-0.11%
Change (1 day)
-19.01%
Change (1 year)

Operating Margin for GlaxoSmithKline (GSK)

Operating Margin as of March 2023 (TTM): 19.52%

According to GlaxoSmithKline's latest financial reports and stock price the company's current Operating Margin is 19.52%. At the end of 2021 the company had an Operating Margin of 18.23%.

Operating Margin history for GlaxoSmithKline from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202118.23%-20.55%
202022.94%8.99%
201921.05%16.47%
201818.08%28.05%
201714.12%48.22%
20169.52%-79.77%
201547.07%195%
201415.96%-42.75%
201327.87%-1.15%
201228.19%-9.13%
201131.03%120.88%
201014.05%-54.06%
200930.58%-0.75%
200830.81%-14.58%
200736.06%7.28%
200633.62%1901.06%
20051.68%-94.44%
200430.21%1.33%
200329.81%10.7%
200226.93%-9.4%
200129.72%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
16.15%-17.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
29.90% 53.18%๐Ÿ‡บ๐Ÿ‡ธ USA
19.90% 1.95%๐Ÿ‡ซ๐Ÿ‡ท France
28.49% 45.95%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.70%-103.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.14%-78.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
17.64%-9.63%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.